Chr. Hansen probiotics halve risk of NEC, study
date:Dec 18, 2013
the condition don't survive.

Including 1,100 premature infants, the international study coordinated by Associate Professor Sue Jacobs and Professor Suzanne Garland at the Royal Women's Hospital in Melbourne, Australia is the largest within this indication to date.

It is a very well-designed, large-scale study and I consider this extremely strong data within an important indication, said Chr. Hansens Dorte Eskesen, senior scientific advisor, health nutrition division. I am impressed that the
2/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/28 12:13